Pulsed-field gel electrophoresis typing of Escherichia coli strains from samples collected before and after pivmecillinam or placebo treatment of uncomplicated community-acquired urinary tract infection in women

Journal of Clinical Microbiology

Volumn 44, Issue 5, 2006, Pages 1776-1781

  Ejrnaes, Karen ^a   Sandvang, Dorthe ^a   Lundgren, Bettina ^b   Ferry, Sven ^b,c   Holm, Stig ^b,d   Monsen, Tor ^b   Lundholm, Rolf ^b   Frimodt Moller, Niels ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b Department of Clinical Microbiology ^*  (Sweden)

^c Umea Primary Health Care Centre   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PIVMECILLINAM; PLACEBO;

ADULT; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL STRAIN; BLADDER EPITHELIUM; ESCHERICHIA COLI; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PULSED FIELD GEL ELECTROPHORESIS; REINFECTION; RELAPSE; URINARY TRACT; URINARY TRACT INFECTION;

ADULT; AMDINOCILLIN PIVOXIL; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; COMMUNITY-ACQUIRED INFECTIONS; DNA, BACTERIAL; DOUBLE-BLIND METHOD; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; RECURRENCE; SPECIES SPECIFICITY; URINARY TRACT INFECTIONS;

ESCHERICHIA COLI;

EID: 33646561821     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.44.5.1776-1781.2006     Document Type: Article

References (46)

1. Anderson, G. G., J. J. Palermo, J. D. Schilling, R. Roth, J. Heuser, and S. J. Hultgren. 2003. Intracellular bacterial biofilm-like pods in urinary tract infections. Science 301:105-107.
2. Bergstrom, T., K. Lincoln, F. Orskov, I. Orskov, and J. Winberg. 1967. Studies of urinary tract infections in infancy and childhood. 8. Reinfection vs. relapse in recurrent urinary tract infections. Evaluation by means of identification of infecting organisms. J. Pediatr. 71:13-20.
3. Bingen, E., M. Rangaraj, and C. Safran. 1994. Ribotyping differentiates relapse from reinfection in the treatment failures of Escherichia coli urinary tract infections in children. Diagn. Microbiol. Infect. Dis. 18:263-265.
4. Bouza, E., R. San Juan, P. Munoz, A. Voss, J. Kluytmans, et al. 2001. A European perspective on nosocomial urinary tract infections II. Report on incidence, clinical characteristics and outcome (ESGNI-004 study). Clin. Microbiol. Infect. 7:532-542.
5. Brauner, A., S. H. Jacobson, and I. Kuhn. 1992. Urinary Escherichia coli causing recurrent infections-a prospective follow-up of biochemical phenotypes. Clin. Nephrol. 38:318-323.
6. Edlund, C., and C. E. Nord. 2000. Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections. J. Antimicrob. Chemother. 46(Suppl. 1):41-48.
7. Elliott, T. S., L. Reed, R. C. Slack, and M. C. Bishop. 1985. Bacteriology and ultrastructure of the bladder in patients with urinary tract infections. J. Infect. 11:191-199.
8. Ferry, S., L. G. Burman, and B. Mattsson. 1987. Urinary tract infection in primary health care in northern Sweden. I. Epidemiology. Scand. J. Prim. Health Care 5:123-128.
9. Ferry, S. A., S. E. Holm, H. Stenlund, R. Lundholm, and T. J. Monsen. 2004. The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study. Scand. J. Infect. Dis. 36:296-301.
10. Foxman, B. 1990. Recurring urinary tract infection: incidence and risk factors. Am. J. Public Health 80:331-333.
11. Foxman, B., R. Barlow, H. D'Arcy, B. Gillespie, and J. D. Sobel. 2000. Urinary tract infection: self-reported incidence and associated costs. Ann. Epidemiol. 10:509-515.
12. Foxman, B., B. Gillespie, J. Koopman, L. Zhang, K. Palin, P. Tallman, J. V. Marsh, S. Spear, J. D. Sobel, M. J. Marty, and C. F. Marrs. 2000. Risk factors for second urinary tract infection among college women. Am. J. Epidemiol. 151:1194-1205.
13. Foxman, B., L. Zhang, P. Tallman, K. Palin, C. Rode, C. Bloch, B. Gillespie, and C. F. Marrs. 1995. Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection. J. Infect. Dis. 172:1536-1541.
14. Haley, R. W., D. H. Culver, J. W. White, W. M. Morgan, T. G. Emori, V. P. Munn, and T. M. Hooton. 1985. The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am. J. Epidemiol. 121:182-205.
15. Hooton, T. M. 2001. Recurrent urinary tract infection in women. Int. J. Antimicrob. Agents 17:259-268.
16. Hooton, T. M., D. Scholes, J. P. Hughes, C. Winter, P. L. Roberts, A. E. Stapleton, A. Stergachis, and W. E. Stamm. 1996. A prospective study of risk factors for symptomatic urinary tract infection in young women. N. Engl. J. Med. 335:468-474.
17. Hooton, T. M., and W. E. Stamm. 1997. Diagnosis and treatment of uncom-plicated urinary tract infection. Infect. Dis. Clin. N. Am. 11:551-581.
18. Hvidberg, H., C. Struve, K. A. Krogfelt, N. Christensen, S. N. Rasmussen, and N. Frimodt-Moller. 2000. Development of a long-term ascending urinary tract infection mouse model for antibiotic treatment studies. Antimicrob. Agents Chemother. 44:156-163.
19. Ikaheimo, R., A. Siltonen, T. Heiskanen, U. Karkkainen, P. Kuosmanen, P. Lipponen, and P. H. Makela. 1996. Recurrence of urinary tract infection in a primary care setting: analysis of a 1-year follow-up of 179 women. Clin. Infect. Dis. 22:91-99.
20. Jacobson, S. H., I. Kuhn, and A. Brauner. 1992. Biochemical fingerprinting of urinary Escherichia coli causing recurrent infections in women with pyelonephritic renal scarring. Scand. J. Urol. Nephrol. 26:373-377.
21. Jantunen, M. E., H. Saxen, S. Lukinmaa, M. Ala-Houhala, and A. Siitonen. 2001. Genomic identity of pyelonephritogenic Escherichia coli isolated from blood, urine and faeces of children with urosepsis. J. Med. Microbiol. 50:650-652.
22. Jantunen, M. E., H. Saxen, E. Salo, and A. Siitonen. 2002. Recurrent urinary tract infections in infancy: relapses or reinfections? J. Infect. Dis. 185:375-379.
23. Justice, S. S., C. Hung, J. A. Theriot, D. A. Fletcher, G. G. Anderson, M. J. Footer, and S. J. Hultgren. 2004. Differentiation and developmental pathways of uropathogenic Escherichia coli in urinary tract pathogenesis. Proc. Natl. Acad. Sci. USA 101:1333-1338.
24. Kahlmeter, G. 2000. The ECO.SENS Project: a prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens-interim report. J. Antimicrob. Chemother. 46(Suppl. 1):15-22.
25. Karkkainen, U. M., R. Ikaheimo, M. L. Katila, and A. Siitonen. 2000. Recurrence of urinary tract infections in adult patients with community-acquired pyelonephritis caused by E. coli: a 1-year follow-up. Scand. J. Infect. Dis. 32:495-499.
26. Kerrn, M. B., C. Struve, J. Blom, N. Frimodt-Moller, and K. A. Krogfelt. 2005. Intracellular persistence of Escherichia coli in urinary bladders from mecillinam-treated mice. J. Antimicrob. Chemother. 55:383-386.
27. Knothe, H. 1976. The influence of pivmecillinam on the human gut flora. Arzneimittelforschung 26:427-431. (In German.)
28. Kunin, C. M. 1970. A ten-year study of bacteriuria in schoolgirls: final report of bacteriologic, urologic, and epidemiologic findings. J. Infect. Dis. 122:382-393.
29. Kunin, C. M. 1994. Urinary tract infections in females. Clin. Infect. Dis. 18:1-10.
30. Martinez, J. J., M. A. Mulvey, J. D. Schilling, J. S. Pinkner, and S. J. Hultgren. 2000. Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J. 19:2803-2812.
31. McGeachie, J. 1966. Recurrent infection of the urinary tract: reinfection or recrudescence. Br. Med. J. 1:952-954.
32. Mobley, H. L., and J. W. Warren. 1996. Urinary tract infections: molecular pathogenesis and clinical management. ASM Press, Washington, D.C.
33. Moller, J. K., and A. Stenderup. 1984. The influence of long-term treatment with mecillinam on fecal Escherichia coli. Scand. J. Infect. Dis. 16:223-224.
34. Mulvey, M. A., Y. S. Lopez-Boado, C. L. Wilson, R. Roth, W. C. Parks, J. Heuser, and S. J. Hultgren. 1998. Induction and evasion of host defenses by type 1-piliated uropathogenic Escherichia coli. Science 282:1494-1497.
35. Mulvey, M. A., J. D. Schilling, and S. J. Hultgren. 2001. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect. Immun. 69:4572-4579.
36. Navas-Nacher, E. L., F. Dardick, M. F. Venegas, B. E. Anderson, A. J. Schaeffer, and J. L. Duncan. 2001. Relatedness of Escherichia coli colonizing women longitudinally. Mol. Urol. 5:31-36.
37. Pfau, A., and T. Sacks. 1981. The bacterial flora of the vaginal vestibule, urethra and vagina in premenopausal women with recurrent urinary tract infections. J. Urol. 126:630-634.
38. Pryles, C. V., and A. Glagovsky. 1965. Serological characterization of Escherichia coli. Study in acute and recurrent urinary tract infections in infants and children. Pediatrics 36:219-224.
39. Romero, L., L. Lopez, L. Martinez-Martinez, B. Guerra, J. R. Hernandez, and A. Pascual. 2004. Characterization of the first CTX-M-14-producing Salmonella enterica serotype Enteritidis isolate. J. Antimicrob. Chemother. 53:1113-1114.
40. Russo, T. A., A. Stapleton, S. Wenderoth, T. M. Hooton, and W. E. Stamm. 1995. Chromosomal restriction fragment length polymorphism analysis of Escherichia coli strains causing recurrent urinary tract infections in young women. J. Infect. Dis. 172:440-445.
41. Schilling, J. D., R. G. Lorenz, and S. J. Hultgren. 2002. Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli. Infect. Immun. 70:7042-7049.
42. Stamey, T. A., and C. C. Sexton. 1975. The role of vaginal colonization with enterobacteriaceae in recurrent urinary infections. J. Urol. 113:214-217.
43. Sullivan, A., C. Edlund, B. Svenungsson, L. Emtestam, and C. E. Nord. 2001. Effect of perorally administered pivmecillinam on the normal oropharyngeal, intestinal and skin microflora. J. Chemother. 13:299-308.
44. Tenover, F. C., R. D. Arbeit, R. V. Goering, P. A. Mickelsen, B. E. Murray, D. H. Persing, and B. Swaminathan. 1995. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J. Clin. Microbiol. 33:2233-2239.
45. Winberg, J., H. J. Andersen, T. Bergstrom, B. Jacobsson, H. Larson, and K. Lincoln. 1974. Epidemiology of symptomatic urinary tract infection in childhood. Acta Paediatr. Scand. Suppl. 252:1-20.
46. Yamamoto, S., T. Tsukamoto, A. Terai, H. Kurazono, Y. Takeda, and O. Yoshida. 1997. Genetic evidence supporting the fecal-perineal-urethral hypothesis in cystitis caused by Escherichia coli. J. Urol. 157:1127-1129.